Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Health Catalyst Q3 Adj. EPS $0.06, Inline, Sales $76.323M Beat $75.900M Estimate

Author: Benzinga Newsdesk | November 10, 2025 04:04pm
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $76.323 million which beat the analyst consensus estimate of $75.900 million by 0.56 percent. This is a 0.04 percent decrease over sales of $76.353 million the same period last year.

Posted In: HCAT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist